p16 immunohistochemistry alone is a better prognosticator in tonsil cancer than human papillomavirus in situ hybridization with or without p16 immunohistochemistry

References

• Auluck A, Hislop G, Bajdik C, Poh C, Zhang L, Rosin M. Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population: the British Columbia experience. Cancer 2010;116:2635–44.
   PubMed Web of Science ®Google Scholar
• Hammarstedt L, Lindquist D, Dahlstrand H, Romanitan M, Dahlgren LO, Joneberg J, Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006;119:2620–3.
   PubMed Web of Science ®Google Scholar
• Syrjanen K, Syrjanen S, Lamberg M, Pyrhonen S, Nuutinen J. Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg 1983;12:418–24.
   PubMedGoogle Scholar
• Li W, Thompson CH, O'Brien CJ, McNeil EB, Scolyer RA, Cossart YE, Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer 2003;106:553–8.
   PubMed Web of Science ®Google Scholar
• Martinez I, Wang J, Hobson KF, Ferris RL, Khan SA. Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas. Eur J Cancer 2007;43:415–32.
   PubMed Web of Science ®Google Scholar
• D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944–56.
   PubMed Web of Science ®Google Scholar
• Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24–35.
   PubMed Web of Science ®Google Scholar
• Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008;100:261–9.
   PubMed Web of Science ®Google Scholar
• JP, KlussmannWeissenborn SJ, Wieland U, Dries V, Kolligs J, Jungehuelsing M, Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 2001;92:2875–84.
   PubMed Web of Science ®Google Scholar
• Li W, Thompson CH, Xin D, Cossart YE, O'Brien CJ, McNeil EB, Absence of human papillomavirus in tonsillar squamous cell carcinomas from Chinese patients. Am J Pathol 2003;163:2185–9.
   PubMed Web of Science ®Google Scholar
• Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005;14:467–75.
   PubMed Web of Science ®Google Scholar
• Kondoh A, Takano K, Kojima T, Ohkuni T, Kamekura R, Ogasawara N, Altered expression of claudin-1, claudin-7, and tricellulin regardless of human papilloma virus infection in human tonsillar squamous cell carcinoma. Acta Otolaryngol 2011;131:861–8.
   PubMed Web of Science ®Google Scholar
• Park WS, Ryu J, Cho KH, Choi MK, Moon SH, Yun T, Human papillomavirus in oropharyngeal squamous cell carcinomas in korea: use of G1 cycle markers as new prognosticators. Head Neck 2012;34:1408–17.
   PubMed Web of Science ®Google Scholar
• Chien CY, Su CY, Fang FM, Huang HY, Chuang HC, Chen CM, Lower prevalence but favorable survival for human papillomavirus-related squamous cell carcinoma of tonsil in Taiwan. Oral Oncol 2008;44:174–9.
   PubMed Web of Science ®Google Scholar
• Braakhuis BJ, Tabor MP, Leemans CR, van der Waal I, Snow GB, Brakenhoff RH. Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck 2002;24:198–206.
   PubMed Web of Science ®Google Scholar
• Lewis JS, Thorstad WL, Chernock RD, Haughey BH, Yip JH, Zhang Q, p16 positive oropharyngeal squamous cell carcinoma: an entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol 2010;34:1088–96.
   PubMed Web of Science ®Google Scholar
• Thomas J, Primeaux T. Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma? Ann Diagn Pathol 2012;16:91–9.
   PubMedGoogle Scholar
• Smeets SJ, Hesselink AT, Speel EJ, Haesevoets A, Snijders PJ, Pawlita M, A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007;121:2465–72.
   PubMed Web of Science ®Google Scholar
• Schache AG, Liloglou T, Risk JM, Filia A, Jones TM, Sheard J, Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination. Clin Cancer Res 2011;17:6262–71.
   PubMed Web of Science ®Google Scholar